BPA Call HHSN263200700065174B-HHSN26100011
Award Date 9/20/15
Potential Completion Date 10/6/15
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $19,961.98 purchase order to Cell Culture Collective, Inc. for fetal bovine serum. Cell Culture Collective, Inc. will deliver the requested serum to support biomedical research efforts under this firm fixed price contract. Performance will take place in Encinitas, California over a one-month period concluding in late September 2023. No set aside designation or subcontractors were...
- This is a purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Sigma-Aldrich, Inc. for the delivery of fetal bovine serum. The contract has a firm fixed price of $14,300.00 and an ultimate completion date of September 9, 2016. Sigma-Aldrich, Inc. is a foreign-owned, for-profit organization that provides specialized laboratory supplies, chemicals, and materials to support...
- The National Cancer Institute awarded a $24.9K firm fixed-price contract to Research and Diagnostic Systems, Inc. (R&D Systems) on May 25, 2021, for the purchase of eighty-three 500 ml bottles of fetal bovine serum, Lot #K19150. This contract was executed as a call against an existing Blanket Purchase Agreement and represents a non-competitive procurement. The place of performance is Minneapolis, Minnesota, where R&D Systems maintains its headquarters as a subsidiary of Bio-Techne...
- The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to Atlanta Biologicals, Inc., a subsidiary of Bio-Techne Corporation, for the supply of Fetal Bovine Serum (FBS) Optima under Quote #51139. This firm fixed-price contract, with a ceiling value of $8,857.30, was executed on June 27, 2018, with an ultimate completion date of July 26, 2018. The contract was fulfilled at the vendor's facility in Flowery Branch, Georgia, and was not designated as a set-aside contract. Fetal...
- This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Sigma-Aldrich, Inc., doing business as Sigma-Aldrich Sales, Inc., for the delivery of Fetal Bovine Serum. The $15,000.00 firm-fixed-price purchase order does not have a set-aside designation and was awarded on November 26, 2018 with a completion date of December 28, 2018. Sigma-Aldrich is a leading life science...
- The National Cancer Institute awarded a $14,976 firm fixed-price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on August 18, 2021, for the supply of Fetal Bovine Serum – Optima, with performance completion by September 30, 2021. The award was made through open competition with no set-aside designation. R&D Systems, a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, specializes in...
- Sigma-Aldrich, Inc. received a Blanket Purchase Agreement (BPA) call valued at $11,552.00 from the National Cancer Institute, a civilian agency under the National Institutes of Health, with an award date of July 28, 2016, and ultimate completion date of August 5, 2016. This contract represents a child order placed against a larger indefinite delivery vehicle and was structured as a fixed-price agreement with economic price adjustment provisions. No small business set-aside was utilized for...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Sigma-Aldrich Corporation. The contract is for the delivery of fetal bovine serum from USDA-approved countries, in the amount of $14,998.00. The contract does not have a set-aside designation. Sigma-Aldrich Corporation is a leading supplier of laboratory chemicals and related products, and has previously served as a...
- The National Cancer Institute awarded a $16,250 firm fixed price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on May 5, 2021, for fetal bovine serum premium in 500 mL quantities. The contract, which was completed by May 27, 2021, was performed in Minneapolis, Minnesota, where R&D Systems is headquartered. No set-aside designation was used for this procurement, indicating open competition. R&D Systems, a subsidiary of Bio-Techne...
- This $14,250 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Sigma-Aldrich, Inc. (doing business as Sigma-Aldrich Sales, Inc.) for the provision of fetal bovine serum. Sigma-Aldrich is a foreign-owned, for-profit organization that supplies specialized laboratory supplies, chemicals, and materials to support scientific research and development across federal...